Luke Utley

Title: Luke Utley: Innovator in Pharmaceutical Formulations

Introduction

Luke Utley is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His work focuses on improving the efficacy and delivery of medications.

Latest Patents

Luke Utley holds a patent for "Tebipenem pivoxil immediate and modified release oral dosage forms." This patent includes immediate and modified release oral dosage forms of tebipenem pivoxil, which consists of dosage form cores containing tebipenem pivoxil in free base or salt form. The formulation also includes excipients such as a binder, a lubricant, and optionally a diluent. The weight to weight ratio of tebipenem pivoxil to the excipients in the dosage form core ranges from 30:60 to 60:30. The patent also discloses methods for treating bacterial infections, including complicated urinary tract infections.

Career Highlights

Luke is currently employed at Spero Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work is instrumental in developing new treatment options for patients with bacterial infections.

Collaborations

Luke collaborates with talented colleagues, including Shaoqiong Lyu and Shoufeng Li, who contribute to the advancement of their projects and research initiatives.

Conclusion

Luke Utley's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His patent on tebipenem pivoxil showcases his expertise and dedication to addressing critical medical needs.